Xeris Biopharma Holdings Inc (XERS)
2.87
+0.05
(+1.77%)
USD |
NASDAQ |
Sep 27, 16:00
2.87
0.00 (0.00%)
After-Hours: 18:33
Xeris Biopharma Holdings Free Cash Flow: -38.83M for June 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
Date | Value |
---|---|
June 30, 2024 | -38.83M |
March 31, 2024 | -43.38M |
December 31, 2023 | -49.29M |
September 30, 2023 | -72.88M |
June 30, 2023 | -75.85M |
March 31, 2023 | -81.38M |
December 31, 2022 | -103.42M |
September 30, 2022 | -116.24M |
June 30, 2022 | -121.23M |
March 31, 2022 | -120.64M |
December 31, 2021 | -96.62M |
September 30, 2021 | -78.64M |
June 30, 2021 | -72.68M |
March 31, 2021 | -76.35M |
Date | Value |
---|---|
December 31, 2020 | -80.94M |
September 30, 2020 | -99.66M |
June 30, 2020 | -113.64M |
March 31, 2020 | -113.07M |
December 31, 2019 | -105.45M |
September 30, 2019 | -94.22M |
June 30, 2019 | -79.96M |
March 31, 2019 | -71.00M |
December 31, 2018 | -57.79M |
September 30, 2018 | -48.54M |
June 30, 2018 | -37.45M |
March 31, 2018 | -29.64M |
December 31, 2017 | -25.36M |
Free Cash Flow Range, Past 5 Years
-121.23M
Minimum
Jun 2022
-38.83M
Maximum
Jun 2024
-87.72M
Average
-87.80M
Median
Free Cash Flow Benchmarks
Zoetis Inc | 2.103B |
NovaBay Pharmaceuticals Inc | -3.396M |
Palatin Technologies Inc | -33.83M |
iBio Inc | -18.55M |
Theriva Biologics Inc | -18.01M |
Free Cash Flow Related Metrics
Cash from Operations (Quarterly) | -10.35M |
Cash from Investing (Quarterly) | 4.603M |
Cash from Financing (Quarterly) | 0.659M |
Free Cash Flow Per Share (Quarterly) | -0.0724 |
Free Cash Flow to Equity (Quarterly) | -11.55M |
Free Cash Flow to Firm (Quarterly) | -3.721M |
Free Cash Flow Yield | -9.58% |